Jan Aushadhi shops can replace branded drugs with generics

NEW DELHI: To promote low-cost generic medicines, the government’s top drug regulatory board has allowed Jan Aushadhi Kendras — which are like fair price shops for medicines under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana — to substitute doctor’s prescription with a generic brand.

On Thursday, the Drugs Technical Advisory Board cleared a proposal to amend a rule under the drugs law. “This proposal asking permission for chemists to substitute brands prescribed by doctors with other brands was pending for a very long time. For the time being, we have allowed only Jan Aushadhi stores to do so because we want to watch it on a trial basis,” an official said. So far, chemists were legally not allowed to replace the brand or the medicine prescribed by a doctor.

The official said allowing all retailers to substitute medicine brands may open up the market to corruption as chemists may push brands with higher margin. The move is also likely to promote Jan Aushadhi stores which have failed to take off as well as intended in the last few years. At present, there are over 4,000 Jan Aushadhi stores.

  • Related Posts

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid